Abstract
The importance of serum amyloid A protein in the progression of renal failure was studied over three years in 28 patients with secondary (amyloid A type) amyloidosis predominantly due to rheumatoid arthritis. Creatinine clearance, the amount of protein in the urine, and serum amyloid A and C-reactive protein concentrations were determined regularly. Linear regression analysis showed a close correlation between the change in creatinine clearance each year and both serum amyloid A concentrations (20 patients: r= -0.83, p less than 0.001) and C-reactive protein concentrations (28 patients: r= -0.80, p less than 0.001). The correlation between serum amyloid A and C-reactive protein concentrations was also significant (317 parallel measurements: r=0.81, p less than 0.001). These findings suggest that monitoring serum amyloid A or C-reactive protein concentrations is valuable in assessing the prognosis in secondary amyloidosis and that therapeutic measures that lower serum amyloid A concentrations may reduce the formation of amyloid.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Benson M. D., Cohen A. S. Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases. Arthritis Rheum. 1979 Jan;22(1):36–42. doi: 10.1002/art.1780220106. [DOI] [PubMed] [Google Scholar]
- Dikman S. H., Churg J., Kahn T. Morphologic and clinical correlates in renal amyloidosis. Hum Pathol. 1981 Feb;12(2):160–169. doi: 10.1016/s0046-8177(81)80103-7. [DOI] [PubMed] [Google Scholar]
- Husby G., Natvig J. B. A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest. 1974 Apr;53(4):1054–1061. doi: 10.1172/JCI107642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Levin M., Franklin E. C., Frangione B., Pras M. The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest. 1972 Oct;51(10):2773–2776. doi: 10.1172/JCI107098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Linke R. P., Sipe J. D., Pollock P. S., Ignaczak T. F., Glenner G. G. Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1473–1476. doi: 10.1073/pnas.72.4.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mackensen S., Grund K. E., Bader R., Bohle A. The influence of glomerular and interstitial factors on the serum creatinine concentration in renal amyloidosis. Virchows Arch A Pathol Anat Histol. 1977 Sep 28;375(3):159–168. doi: 10.1007/BF01102985. [DOI] [PubMed] [Google Scholar]
- Maury C. P., Teppo A. M. Mechanism of reduced amyloid-A-degrading activity in serum of patients with secondary amyloidosis. Lancet. 1982 Jul 31;2(8292):234–237. doi: 10.1016/s0140-6736(82)90322-1. [DOI] [PubMed] [Google Scholar]
- Maury C. P., Teppo A. M., Wegelius O. Relationship between urinary sialylated saccharides, serum amyloid A protein, and C-reactive protein in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 1982 Jun;41(3):268–271. doi: 10.1136/ard.41.3.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosenthal C. J., Franklin E. C. Variation with age and disease of an amyloid A protein-related serum component. J Clin Invest. 1975 Apr;55(4):746–753. doi: 10.1172/JCI107985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wangel A. G., Wegelius O., Dyrting A. E. A family study of leprosy: subcutaneous amyloid deposits and humoral immune responses. Int J Lepr Other Mycobact Dis. 1982 Mar;50(1):47–55. [PubMed] [Google Scholar]
- Wegelius O., Teppo A. M., Maury C. P. Reduced amyloid-A-degrading activity in serum in amyloidosis associated with rheumatoid arthritis. Br Med J (Clin Res Ed) 1982 Feb 27;284(6316):617–619. doi: 10.1136/bmj.284.6316.617. [DOI] [PMC free article] [PubMed] [Google Scholar]